Navigation Links
Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
Date:4/14/2011

ERIE, Pa., April 14, 2011 /PRNewswire/ -- In an effort to match last year's $250,000 Pepsi Refresh Everything grant, the Kanzius Cancer Research Foundation (KCRF) launched the "Repeat the Wave" Campaign on April 1 raising over $40,000 and adding more than 4,000 new Facebook fans in thirteen days. Until April 30, KCRF is increasing awareness and raising additional funds for research of the Kanzius Non-Invasive Radiowave Cancer Treatment by asking the public to "like" them on Facebook.

An anonymous donor has agreed to donate one dollar for each new KCRF Facebook fan as well as match fifty cents for each dollar donated to the Foundation. After a Facebook user likes the page, they are then encouraged to "Spread the Wave" by inviting all of their Facebook friends to also "like" the Kanzius Cancer Research Foundation page. The campaign urges KCRF supporters to use a special landing page, www.RepeatTheWave.com, and invite their social networks to spread the wave just like last April, when Internet users and Facebook fans voted KCRF's project as the most "refreshing idea" during the Pepsi Refresh Everything contest. Since the start of this campaign, KCRF has increased support on local, national and global levels.

"A year ago, we embarked on a journey to 'Spread the Wave' and thanks to overwhelming community support, we won the Pepsi contest resulting in a grant of $250,000 to educate new audiences; this has truly transformed our foundation," said Mark A. Neidig, Sr., executive director of Kanzius Foundation. "Today, I am once again humbled by the tremendous support for the 'Repeat the Wave' campaign.  No doubt, everyone has been touched by cancer in some way.  The 'Kanzius Way' of treating cancer non-invasively and without side effects is why we won the grant last year and today, this timely message is still refreshing and worth repeating!"

About the Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c) (3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Non-invasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants.  Pancreatic, liver and colorectal cancers in test subjects are undergoing extensive research in Houston and Pittsburgh; additional, ongoing studies are currently focused on breast, leukemic, lung, melanomic and prostate cancers. John Kanzius' sophisticated radio transmission machine is being manufactured in Erie, Pa.  For more information about the Kanzius research, visit www.Kanzius.org.


'/>"/>
SOURCE Kanzius Cancer Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , May 5, 2016 ... the addition of the  "Europe Thrombocytopenia ... 2016"  report to their offering.  ... ) , ,The latest research Europe ... - 2016, provides comprehensive insights into ...
(Date:5/5/2016)... , May 5, 2016 ... of the  "Europe Systemic Lupus Erythematosus Market ... to their offering.       (Logo: ... latest research Europe Systemic Lupus Erythematosus Market ... comprehensive insights into Systemic Lupus Erythematosus pipeline ...
(Date:5/4/2016)... 4, 2016 According to a ... Computer Interface Market - Global Industry Analysis, Size, Share, ... computer interface (BCI) market  is expected to reach a ... estimated to expand at a CAGR of 14.9 % ... A BCI device provides collaboration between the brain ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... This weekend, from Friday, May 6 - Sunday, May 8, ... terrain at the first Team Semper Fi Mountain Bike Camp, hosted in conjunction with ... bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with the injured veterans ...
(Date:5/5/2016)... Stockholm/San Jose (PRWEB) , ... May 05, 2016 , ... ... the art of self-love. Every day, LELO fans reach out via email, social media ... recurring question keeps upcoming up: “Is the way I masturbate ‘normal’ or ‘correct’?” , ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... in all U.S. states and certain Canadian provinces is now available from the ... Research Institute (WCRI). , The report, Workers’ Compensation Laws as of ...
(Date:5/5/2016)... New York (PRWEB) , ... May 05, 2016 , ... ... today announced the merger of noted Long Island eye surgeon, Kathleen Van Valkenburg, MD ... City practice, according to Jeffrey Martin, MD, medical director and managing partner of North ...
(Date:5/5/2016)... ... 05, 2016 , ... Standard Process Inc. announces ... United States. The whole food nutrient solutions company can help veterinarians grow their ... and horse owners’ peace of mind. With the increased support, veterinarian customers can ...
Breaking Medicine News(10 mins):